NKE
39
2
HAL
50
4
TXT
75
6
URBN
60
-3
L
63
3
IFF
69
13
PFE
37
-3
BIIB
45
-3
C
48
-2
EA
47
-3
MTCH
44
-2
HD
35
-11
BLK
69
11
CMCSA
55
-2
COP
47
2
PPL
67
-2
FCX
67
14
DNB
46
-2
PLD
58
10
GOOGL
61
-11
NKE
39
2
HAL
50
4
TXT
75
6
URBN
60
-3
L
63
3
IFF
69
13
PFE
37
-3
BIIB
45
-3
C
48
-2
EA
47
-3
MTCH
44
-2
HD
35
-11
BLK
69
11
CMCSA
55
-2
COP
47
2
PPL
67
-2
FCX
67
14
DNB
46
-2
PLD
58
10
GOOGL
61
-11
Financhill
Back

Cytokinetics Stock Predictions

Sell
38

CYTK
Cytokinetics

Last Price:
59.57
Seasonality Move:
8.8%

7 Day Trial

ALL ACCESS PASS

$ 7

Cytokinetics Stock Forecast

  • Over the next 52 weeks, Cytokinetics has on average historically risen by 12.8% based on the past 20 years of stock performance.
  • Cytokinetics has risen higher in 11 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 55%
  • Is Cytokinetics Stock Undervalued?
    The current Cytokinetics [CYTK] share price is $59.53. The Score for CYTK is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • CYTK is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Cytokinetics Stock Go Up Next Year?

  • Over the next 52 weeks, Cytokinetics has on average historically risen by 12.8% based on the past 20 years of stock performance.

Cytokinetics Stock Rating

Sell
38
Cytokinetics (CYTK) is a Sell

Is Cytokinetics overpriced?

  • Cytokinetics has risen higher in 11 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 55%

Cytokinetics Stock Price History

Is CYTK stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cytokinetics.com

52-Week Data

52-Week High:
110.25
52-Week Low:
25.98

Prediction Charts

Market Cap:
6.24B
Price in USD:
59.53
Volume:
1.06M
Beta:
1.47

Technical Analysis

SMA50:
66.63
SMA100:
73.44
SMA200:
53.45
52-Wk Change:
57.45%

Stock Predictions

  • Is Cytokinetics stock public?
    Yes, Cytokinetics is a publicly traded company.
  • What is the Cytokinetics stock quote today?
    The Cytokinetics stock price is 59.53 USD today.
  • How to buy Cytokinetics stock online?
    You can buy Cytokinetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-30 61.74 61.32 62.28 60.86
May-1 61.41 63.37 64.30 61.37
May-2 64.33 64.38 64.69 63.57
May-3 66.08 65.27 66.61 65.00
May-6 65.68 65.05 66.40 63.41
May-7 65.74 65.30 66.52 64.53
May-8 65.00 65.27 66.25 64.52
May-9 68.21 64.03 68.44 61.75
May-10 63.63 62.10 64.61 61.25
May-13 63.33 57.89 63.46 55.91
May-14 58.06 59.36 60.33 57.02
May-15 60.27 60.50 60.99 58.33
May-16 60.68 59.92 61.04 59.50
May-17 59.62 59.53 60.47 58.64

Cytokinetics Earnings

Cytokinetics Earnings Report: Per Share Cytokinetics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Cytokinetics Forecast Revenue Growth

Cytokinetics Stock Analysis: Historical quarterly revenues per share for Cytokinetics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.37 per share, an increase next quarter of $0.02 per share, an increase this year of $0.18 per share, and an increase next year of $0.61 per share.

* Cytokinetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.